ERIN MARIE KROPP, MD

Plain English
This study looked at a protein called SEL1L, which is linked to how platelets (the cells that help blood to clot) work. Researchers found that a specific change in the SEL1L gene in horses with a bleeding disorder led to lower amounts of this protein, which resulted in poor platelet function. In tests with mice and zebrafish, they discovered that SEL1L is crucial for platelets to stick to damaged blood vessels, suggesting that problems with this protein could also affect human blood conditions. Who this helps: Patients with blood clotting disorders.

Plain English
Researchers tested thousands of existing drugs to find new ways to kill multiple myeloma cancer cells, and discovered that a drug called RTA408 works by blocking a cellular cleanup system that myeloma cells depend on to survive. When RTA408 shuts down this cleanup system, cancer cells die through a specific mechanism involving the cell's outer membrane, and it kills even myeloma cells that have become resistant to current treatments. This finding could lead to a new treatment option for multiple myeloma patients who no longer respond to standard drugs.

Plain English
This research looked at how a protein called PERK affects blood stem cells (HSCs) when they are under stress. The study found that while PERK isn't needed for normal blood cell production, it plays a key role during stress by causing HSCs to multiply too much and eventually lose their ability to renew themselves. Specifically, when certain stress-related processes were disrupted, removing PERK improved the overall health of these stem cells by preventing this overgrowth. Who this helps: This helps patients who rely on healthy blood stem cells, such as those undergoing chemotherapy.

Plain English
This study looked at a protein called SEL1L, which is found in platelets (the cells that help blood clot) and is linked to a rare blood disorder in horses. Researchers discovered that a specific genetic change in horses with this disorder caused lower levels of SEL1L, leading to problems with their platelets sticking to damaged blood vessels. They also found that SEL1L is crucial for platelets in mice and zebrafish to effectively adhere to injury sites, showing that this protein is important for proper blood clotting in several species, including humans. Who this helps: This research benefits patients with platelet disorders and doctors treating these conditions.

Plain English
Researchers tested thousands of existing drugs to find one that could block a cellular cleanup system called ERAD, and discovered that a drug called omaveloxolone (RTA408) does this effectively. When they applied this drug to multiple myeloma cancer cells—including ones that resist other treatments—it triggered the cancer cells to self-destruct by activating their internal death signals. This matters because multiple myeloma is currently incurable, and omaveloxolone could become a new treatment option, either alone or combined with existing drugs.

Plain English
This research focused on how a protein called PERK helps maintain healthy blood-forming stem cells during stress conditions. The study found that when certain stress triggers were activated, PERK encouraged the stem cells to multiply rapidly and remove damaged ones, which is crucial for keeping the pool of healthy stem cells intact. Specifically, when PERK was disrupted, it caused significant deficits in these stem cells, allowing them to thrive under normal conditions but failing to protect them from stress. Who this helps: Patients needing blood-related treatments, as well as doctors managing blood cell health.

Plain English
Researchers studied how nitric oxide (a molecule produced in the body) affects insulin-producing cells in the pancreas, and found that it shuts down the cells' ability to take in and process glucose (sugar) by depleting their energy supply. The nitric oxide specifically blocks the cells' energy-making machinery in their mitochondria, causing ATP (the cell's fuel) to drop so low that the cells can no longer absorb glucose, putting them into a dormant state. This matters because it reveals a unique vulnerability of pancreatic insulin cells compared to other cell types, which could help explain problems with blood sugar control and potentially lead to new treatments for diabetes.

Plain English
This study looked at why some patients with relapsed or refractory acute myeloid leukemia (AML) don’t respond to new targeted treatments. Despite advances in therapies that can help some patients live longer, many still face treatment resistance and relapse; for instance, most patients who initially do well with these therapies eventually stop responding. Understanding these resistance mechanisms is crucial because it could lead to better treatments and improved outcomes for patients. Who this helps: Patients with relapsed or refractory AML.

Plain English
This research focused on improving the way scientists identify heart cells derived from stem cells, called cardiomyocytes, using a laboratory technique called flow cytometry. The study found that different methods and preparations led to inconsistent results, highlighting that some well-known procedures might not be reliable. This is important because accurate identification of these cells is essential for conducting and comparing research across different labs. Who this helps: This helps researchers working with heart cells and potentially benefits patients by improving the development of heart-related therapies.

Plain English
This study looked at how heart cells made from human stem cells (hPSC) can survive when a specific enzyme, NAMPT, is blocked. The researchers found that after 28 days of differentiation, these heart cells can keep producing energy, allowing them to withstand the effects of NAMPT inhibitors for longer periods, while earlier-stage cells cannot. Understanding this process is important because it helps ensure that potential treatments using these stem cells are safe and effective, reducing the risk of unwanted tumor growth. Who this helps: Patients needing heart treatments derived from stem cells.

Plain English
Researchers found that a drug called STF-31 can kill undifferentiated stem cells while leaving normal cells alone, by blocking a specific pathway cells use to recycle a molecule called NAD⁺. This matters because stem cell therapies have a cancer risk—if any undifferentiated stem cells slip into a treatment, they could form tumors—so a way to reliably eliminate them before use makes these therapies much safer to use in patients.

Plain English
This study looked at the proteins on the surface of mouse cells during early development to understand their roles better. Researchers identified over 600 unique surface proteins from different types of cells, which could help in pinpointing specific cell types. This discovery is important because it can improve how scientists identify and isolate cells, aiding in research on diseases and drug development. Who this helps: This helps researchers and scientists working on stem cell therapies and disease treatments.

Plain English
Researchers studied the surface proteins of human pluripotent stem cells (hPSCs) and identified 496 specific proteins on these cells that can help in isolating and understanding them better. Among these, they found more than 100 proteins that are particularly important for recognizing and characterizing hPSCs, with over 30 markers verified through different testing methods. This research is important because it improves our ability to isolate hPSCs for medical use and highlights a drug, STF-31, that can selectively eliminate hPSCs from mixed cell cultures without harming other cells. Who this helps: This benefits researchers and doctors who work with stem cells in treatments and therapies.

Plain English
This study focused on creating heart muscle cells from human stem cells more efficiently to help with heart disease research and treatment. The researchers developed a new method that produces a high quantity of heart cells, showing that over 90% of the cells tested had important heart markers by day 10. This advancement is significant because it simplifies the process and reduces costs, making it easier to study heart conditions and test new drugs. Who this helps: This helps patients with heart disease and doctors looking for better treatments.

Plain English
This study looked at how a protein called CHOP affects liver disease in mice. Researchers found that mice lacking this protein (Chop(-/-) mice) suffered more liver damage and inflammation compared to normal mice (Chop(+/+) mice). Specifically, the Chop(-/-) mice showed increased liver injury and immune cell activation, which suggests that CHOP helps protect the liver from inflammation in fatty liver disease by promoting the death of certain immune cells that can cause harm. Who this helps: This research benefits patients with nonalcoholic fatty liver disease and their doctors by providing insights into potential new treatment targets.